Invention Grant
- Patent Title: Halogenated rhodamine derivatives and applications thereof
-
Application No.: US13752204Application Date: 2013-01-28
-
Publication No.: US09636363B2Publication Date: 2017-05-02
- Inventor: Abdelkrim Habi , Denis Gravel , Luc Villeneuve , Hongsheng Su , Marc Vaillancourt
- Applicant: KIADIS PHARMA CANADA INC.
- Applicant Address: CA Saint Lambert, QC
- Assignee: Kiadis Pharma Canada Inc.
- Current Assignee: Kiadis Pharma Canada Inc.
- Current Assignee Address: CA Saint Lambert, QC
- Agency: O'Melveny & Myers LLP
- Priority: CA2342675 20010402
- Main IPC: A61K35/28
- IPC: A61K35/28 ; C07D311/82 ; A61K35/14

Abstract:
Methods for treating an infection in a tissue sample are described. Tissue samples that are harvested from a patient may be infected with either bacteria or a virus. A rhodamine compound is mixed with the infected tissue sample to form a mixture. The mixture is then exposed to radiant energy to inhibit or kill the bacteria. The exposed mixture is then transplanted into the patient. The rhodamine compounds may be 2′-(6-dimethylamino-3-dimethylimino-3H-xanthen-9-yl) 4′, 5′-dichloro-benzoic acid methyl ester hydrochloride.
Public/Granted literature
- US20140314720A1 HALOGENATED RHODAMINE DERIVATIVES AND APPLICATIONS THEREOF Public/Granted day:2014-10-23
Information query
IPC分类: